Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
Kidney: Novel Immunosuppressant Strategies
Wednesday August 06, 2025 - 10:00 to 11:15
Room: 155
60.8 Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1B Study
Log in to add to favorites
Add Personal Notes
Eliezer Katz, United States
Presentations by Eliezer Katz
Wed-06 from 10:00 - 11:15 in room 155
Kidney: Novel Immunosuppressant Strategies
Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1B Study
Email:
info@wtc2025.org
514-874-1717
